Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Outcomes of Participants Treated With Teplizumab in Routine Clinical Care

NCT07360080 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT07360080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07360080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Outcomes of Participants Treated With Teplizumab in Routine Clinical Care
Lead sponsor
Sanofi
Phase
Observational
Overall status
Recruiting
Start date
March 19, 2026
Completion date
October 29, 2035
Enrollment
1,000 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes